A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain.
We hypothesized that adenosine, acting via the A1 receptor, is a key factor in the homeostatic control of sleep. The increase in extracellular levels of adenosine during prolonged wakefulness is thought to facilitate the transition to sleep by reducing the discharge activity of wakefulness-promoting neurons in the basal forebrain. Adenosine A1 receptor control of the homeostatic regulation of sleep was tested by microdialysis perfusion of antisense oligonucleotides against the mRNA of the A1 receptor in the magnocellular cholinergic region of the basal forebrain of freely behaving rats. After microdialysis perfusion of A1 receptor antisense in the basal forebrain, spontaneous levels of sleep-wakefulness showed a significant reduction in non-rapid eye movement (REM) sleep with an increase in wakefulness. After 6 hr of sleep deprivation, the antisense-treated animals spent a significantly reduced amount of time in non-REM sleep, with postdeprivation recovery sleep hours 2-5 showing a reduction of approximately 50-60%. There was an even greater postdeprivation reduction in delta power (60-75%) and a concomitant increase in wakefulness. All behavioral state changes returned to control (baseline) values after the cessation of antisense administration. Control experiments with microdialysis perfusion of nonsense (randomized antisense) oligonucleotides and with artificial CSF showed no effect during postdeprivation recovery sleep or spontaneously occurring behavioral states. Antisense to the A1 receptor suppressed A1 receptor immunoreactivity but did not show any neurotoxicity as visualized by Fluoro-Jade staining. These data support our hypothesis that adenosine, acting via the A1 receptor, in the basal forebrain is a key component in the homeostatic regulation of sleep.
Thakkar
Mahesh M
MM
Department of Psychiatry, Harvard Medical School, Veterans Affairs Boston Healthcare System, Brockton Veterans Affairs Medical Center, Brockton, Massachusetts 02301, USA. mthakkar@hms.harvard.edu
Winston
Stuart
S
McCarley
Robert W
RW
D000241:Adenosine / Q000502:physiology*; D000818:Animals; D020532:Basal Nucleus of Meynert / Q000737:chemistry / Q000187:drug effects / Q000502:physiology; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology; D004569:Electroencephalography; D006706:Homeostasis / Q000187:drug effects / Q000502:physiology*; D008297:Male; D017551:Microdialysis; D016376:Oligonucleotides, Antisense / Q000235:genetics / Q000494:pharmacology* / Q000633:toxicity; D010477:Perfusion; D016548:Prosencephalon / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D018047:Receptors, Purinergic P1 / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D012890:Sleep / Q000187:drug effects* / Q000502:physiology*; D012892:Sleep Deprivation / Q000139:chemically induced / Q000503:physiopathology; D012895:Sleep, REM / Q000187:drug effects / Q000502:physiology; D013377:Substantia Innominata / Q000737:chemistry / Q000187:drug effects / Q000502:physiology; D014851:Wakefulness / Q000187:drug effects* / Q000502:physiology*
D016376:Oligonucleotides, Antisense; D018047:Receptors, Purinergic P1; D000241:Adenosine